BibA induces opsonizing antibodies conferring in vivo protection against group B streptococcus

39Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We recently characterized the function of BibA, an immunogenic surface-associated antigen expressed by group B Streptococcus (GBS) that is involved in virulence. In this study, we performed a bibA gene variability analysis on a panel of 72 clinical isolate strains. The bibA gene was present in all the strains analyzed, and 4 allelic variants, correlating with serotype, were identified. Moreover, although the BibA protein was expressed in all strains tested, only 54% of strains demonstrated surface exposure of the antigen in vitro. Importantly, expression of BibA on the bacterial surface was correlated with protection, because mice immunized with BibA were protected against challenge by a GBS strain with high levels of surface exposure of the antigen. In agreement with these findings, serum samples from mice immunized with recombinant BibA induced neutrophil-mediated in vitro opsonophagocytic killing of GBS. In conclusion, we propose BibA as a novel GBS vaccine candidate. © 2009 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Santi, I., Maione, D., Galeotti, C. L., Grandi, G., Telford, J. L., & Soriani, M. (2009). BibA induces opsonizing antibodies conferring in vivo protection against group B streptococcus. Journal of Infectious Diseases, 200(4), 564–570. https://doi.org/10.1086/603540

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free